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Abstract 
In the present study, we describe the cloning and functional characterization of chicken interleukin 26 (ChIL-26). 
ChIL-26, a member of the IL-10 cytokine family, induces the production of proinflammatory cytokines by T cells. The 
ChIL-26 cDNA encodes an 82-amino-acid protein whose amino acid sequence has 22.63, 46.31 and 43.15% homology 
with human IL-26, pig IL-26 and canary IL-26, respectively. ChIL-26 signals through a heterodimeric receptor complex 
composed of the IL-20R1 and IL-10R2 chains, which are expressed primarily in the CU91 T cell line as well as CD4+ and 
CD8+ T cells. Recombinant ChIL-26 protein induced Th1 cytokines (IL-16 and IFN-γ), Th2 cytokines (IL-4, IL-6 and IL-10), 
Th17 cytokines (IL-17A, IL-17D, and IL-17F), and chemokine transcripts (mainly CCL3, CCL4, CCL5, CCL20 and CXCL13) 
in the CU91 T cell line and in CD4+ and CD8+ T cells, however IL-18 was not expressed in the CU91 T cell line. Taken 
together, the data demonstrates that T cells express the functional ChIL-26 receptor complex and that ChIL-26 modu-
lates T cell proliferation and proinflammatory gene expression. To the best of our knowledge, this is the first report of 
cloned ChIL-26. We evaluated its functional roles, particularly in the pathogenic costimulation of T cells, which may be 
significantly associated with the induction of cytokines.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Interleukin 26 (IL-26) was originally discovered in 
humans [1] and zebrafish [2]. Human IL-26 (HuIL-26) 
was cloned as a novel cDNA clone, denoted as AK155, 
displaying weak but significant sequence homology 
(approximately 25% identity) to HuIL-10. The genes 
encoding the ligands of the IL-10 family are located on 
human chromosome 1 (Chr1) (IL-10, IL-19, IL-20, and 
IL-24) [3, 4] and Chr12 (IL-22 and -24), and genes for 
their receptors are located on Chr1 (IL-22R1), Chr3 (IL-
20R2), Chr6 (IL-20R1, IL-22BP, and IFNGR1), Chr11 
(IL-10R1) and Chr21 (IFNAR2, IL-10R2, IFNAR1 and 
IFNGR2) [2, 5].
The HuIL-26 gene is located on chromosome 12q15, 
between the genes for two other important class 2 
cytokines, gamma interferon (IFN-γ) and IL-22. IL-26 
is often coexpressed with IL-22 by activated T cells, 
especially Th17 cells [6, 7]. It signals through a heterodi-
meric receptor complex composed of the IL-20R1 and 
IL-10R2 chains [8]. HuIL-26 receptors are expressed pri-
marily on non-hematopoietic cell types, particularly epi-
thelial cells [7].
In chickens, only four avian members of the IL-10 fam-
ily have been identified: IL-10, IL-19, IL-22, and IL-26. 
Similar to HuIL-26, chicken IL-26 (ChIL-26) is encoded 
in the same cluster with IL-10 on chromosome 26, in a 
syntenic region with human Chr1 [9, 10]. In humans, 
HuIL-26 has been reported to signal via the IL-10R2/
IL-20R1 heterodimeric receptor [8, 11]. While IL-10R2 
is broadly expressed, IL-20R1 is expressed in many epi-
thelial cell types but not in hematopoietic cells [12, 13]. 
The only biological activity of IL-26 reported so far is the 
upregulation of IL-8, IL-10, tumor necrosis factor alpha 
(TNF-α) and CD54 expression in intestinal epithelial cell 
lines, in association with STAT3 and/or STAT1 phospho-
rylation [8, 12].
Recently, HuIL-26 was functionally characterized, and 
His-HuIL-26 was shown to induce IL-10 and IL-8 in 
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the Colo-205 colon cancer cell line and IL-8 in the Lovo 
colon cancer and HaCaT cell lines [8]. HuIL-26 induces 
the production of proinflammatory cytokines and many 
chemokines (mainly CCL20) in myeloid cells and CD4+ T 
cells [14–16]. IL-26 is also produced by activated T cells 
and targets epithelial target cells for signal transduction 
[6, 17]. However, the molecular cloning and functional 
characterization of ChIL-26 have not yet been performed.
We therefore report here, for the first time, the cloning 
and functional characterization of ChIL-26. In addition, 
we examined the biological effects of recombinant ChIL-
26 (rChIL-26) protein in the CU91 chicken T cell line, 
CD4+ T cells, and CD8+ T cells. We observed increased 




To clone full-length ChIL-26, the predicted ChIL-26 cod-
ing sequence (GenBank accession # XM_004937561) was 
amplified from total RNA of the intestinal mucosal layer 
using the following restriction enzyme-anchored prim-
ers: EcoRI-anchored forward primer, 5′-CGGAATTCA 
TGAAAAATGTTTTCAGTCATCTTGG-3′; and HindIII- 
anchored reverse primer, 5′-CCAAGCTTTACTATGG 
TTTGGATGTAGGCCT-3′ (restriction sites are under-
lined). Total RNA was isolated using TRizol reagent 
(Invitrogen, Carlsbad, CA, USA) as described [18] from 
the intestinal mucosal layer of White Leghorn chickens, 
kindly provided by the Animal Biosciences and Biotech-
nology Laboratory (Beltsville, MD, USA) of the USDA-
Agricultural Research Service. The first-strand cDNA was 
subsequently synthesized using a Maxima First Strand 
cDNA synthesis kit (Thermo Scientific Inc., Waltham, 
MA, USA). Polymerase chain reaction (PCR) was per-
formed to amplify the full-length ChIL-26 cDNA, under 
the following conditions: initial denaturation at 94 °C for 
3 min, 35 cycles of denaturation at 94 °C for 30 s, anneal-
ing at 60 °C for 30 s, and extension at 72 °C for 30 s and a 
final extension at 72 °C for 5 min. The newly synthesized 
full-length ChIL-26 gene was directly inserted into the 
pCR2.1-TOPO vector (Invitrogen, Carlsbad, CA, USA), 
followed by transformation into Escherichia coli TOP10 
(Invitrogen). Transformed E. coli TOP10 cells were cul-
tured overnight in Luria–Bertani media (Difco™ and 
BBL™, NJ, USA) at 37 °C. A transformant was selected by 
a combination of PCR screening and sequencing (Geno-
tech Inc., Daejeon, Republic of Korea). For cloning into E. 
coli expression vectors, the ChIL-26-expressing plasmid 
was digested with the endonucleases EcoRI (Invitrogen) 
and HindIII (Promega, Madison, WI, USA). The digested 
ChIL-26 fragment was purified from an agarose gel using 
a QIAQuick gel extraction kit (QIAgen, Valencia, CA, 
USA) and then ligated into digested pET32a (EMD Milli-
pore, Billerica, MA, USA). To express rChIL-26 in E. coli, 
the purified ChIL-26-pET32a plasmid was introduced 
into E. coli BL21 (Invitrogen).
The expression of rChIL-26 was induced by adding 
1  mM IPTG (USB Corporation, Cleveland, OH, USA), 
and bacteria were cultured at 37 °C overnight at 250 rpm. 
The bacterial cells were pelleted by centrifugation at 
3500 × g for 30 min at 4 °C. The supernatant was removed 
and the pellet treated with B-PER bacterial protein extrac-
tion reagent (Thermo Scientific). Recombinant ChIL-26 
was purified using HisPur cobalt resin (Thermo Scientific) 
in the first step of purification as per the manufacturer’s 
instructions. To remove the endotoxin contaminants, 
we combined affinity chromatography with a non-ionic 
detergent washing step as previously described [19]. The 
purified protein was concentrated and the buffer changed 
by ultrafiltration using a 3000-molecular-weight-cutoff 
membrane (EMD Millipore). The samples were dialyzed 
in phosphate-buffered saline (PBS; pH 7.2) overnight, 
using SnakeSkinTM dialysis tubing (Thermo Scientific), 
with stirring, and were analyzed by SDS-PAGE.
Antibodies
The following antibodies were used: anti-chicken CD4 
(IgG1, k) and anti-chicken CD8 monoclonal antibodies 
(CT-8), purchased from LifeSpan BioSciences, Inc. (Seat-
tle, WA, USA), anti-His (C-Term)–horseradish peroxi-
dase (HRP) antibody was purchased from Invitrogen and 
Biotin-labeled goat anti-mouse Ig and Plus-DM strepta-
vidin particles were also purchased from BD Biosciences 
(San Jose, CA, USA).
Isolation of CD4+, CD8+ and splenic T cells
Spleens were obtained from 4 to 5 week-old disease-free 
Ross 308 chicks (YangJi Hatchery, Pyeongtaek, Republic 
of Korea). Total cells were strained through a cell strainer 
(mesh size, 70 µm; Thermo Scientific) into a 50 mL tube. 
CD4+ and CD8+ cells were isolated using a BD IMag 
magnetic bead cell separation system according to the 
manufacturer’s instructions (BD Biosciences Pharmin-
gen) and described previously [20]. Briefly, the cell con-
centration was adjusted to 2 × 107 mL−1 and 50 µg/mL 
of anti-CD4 or anti-CD8 monoclonal antibody (LifeSpan 
BioSciences) was added as determined in preliminary 
titration experiments. The cells were then incubated on 
ice for 45  min and washed twice with Hank’s balanced 
salt solution (HBSS) (Invitrogen) containing 10% fetal 
bovine serum (FBS). Biotinylated goat anti-mouse IgG 
(BD Biosciences Pharmingen) was added at the appro-
priate concentration, and the cells were incubated for 
15  min on ice and then washed with an excess volume 
of 1  ×  BD IMag buffer (BD Biosciences Pharmingen). 
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Next, 50 µL of streptavidin-labeled magnetic particles 
(BD IMag Plus-DM streptavidin particles) per 1  ×  107 
total cells was added, and cells were incubated on ice for 
30 min. Magnetic particles were isolated, and the positive 
and negative cell fractions were suspended in Dulbecco’s 
modified Eagle’s medium (DMEM) containing 10% FBS.
For stimulation of ChIL-26 and its receptors by conca-
navalin A (Con A, Sigma), primary T cells were isolated 
from the spleens of 4 to 5 week-old White Leghorn chick-
ens as previously described [21]. Briefly, splenic T cells 
were prepared and purified using the Histopaque-1077 
(Sigma) density gradient medium by centrifugation at 
400 × g for 20 min to separation of single cell suspension. 
Splenic T cells (1 × 106 cells/well) were cultured in 6-well 
plates (Nunc™, Thermo Scientific) with 5 mL of DMEM 
(Invitrogen, Carlsbad, CA, USA) containing 100  IU/mL 
penicillin, 100 mg/mL streptomycin, and 10% heat-inac-
tivated FBS (Invitrogen) in a humidified 5% CO2 atmos-
phere at 37  °C and 5 μg/mL of Con A was added. Cells 
were harvested after 24, 48 or 72 h of Con A stimulation, 
and total RNA was extracted from cells as described [18].
In vitro biological function analysis
The CU91 chicken T cell line [22] was cultured in DMEM 
(Invitrogen) containing 100 IU/mL penicillin, 100 mg/mL 
streptomycin, and 10% heat-inactivated FBS (Invitrogen) 
in a humidified 5% CO2 atmosphere at 37 °C. The CU91 
T cell line and CD4+ and CD8+ T cells were cultured at 
1 × 106 cells/well in 6-well plates and then treated with 
either medium alone, lipopolysaccharide (LPS) (5 µg/mL; 
from Salmonella enterica serotype Typhimurium; 
(Sigma), rChIL-26 (200  ng/mL) or LPS/rChIL-26). Cells 
were collected at 24, 48 and 72 h post treatment. In pilot 
experiments, rChIL-26 demonstrated a significantly 
greater effect at a concentration of around 200  ng/mL 
for the activation of certain kinases. After incubation, the 
cells were collected and total RNA was extracted from 
cells using TRizol reagent (Invitrogen) and cDNA was 
synthesized as described [18].
Western blotting
The ChIL-26 recombinant protein (100 ng/µL) was sepa-
rated by SDS-PAGE and then transferred to a polyvi-
nylidene difluoride (PVDF) membrane (Invitrogen) using 
an iBlot® gel transfer device (Invitrogen). The trans-
ferred PVDF membrane was blocked with 5% nonfat 
milk (Sigma) dissolved in PBS containing 0.05% Tween 
20 (PBST). The membrane was incubated with anti-His 
(C-Term)–horseradish peroxidase (HRP) antibody over-
night at 4  °C, washed three times with PBST. Detection 
of immunoreactive bands was performed using West-
ern Lightning Plus-ECL substrate (Thermo Scientific) as 
per the supplier’s instructions. A single ChIL-26 protein 
band with an apparent molecular mass of approximately 
33.0  kDa was observed (Figure  1C). The increased size 
over the predicted 10.9 kDa was due to the three epitope 
tags (polyhistidine, S-protein, and thioredoxin) in the 
recombinant protein.
Quantitative real‑time PCR (qRT‑PCR) analysis of cytokine 
transcripts
For analysis of mRNA transcripts, 2  µg of total RNA 
isolated from cells was treated with DNase I (Sigma) 
according to the manufacturer’s instructions to elimi-
nate possible genomic DNA contamination. Briefly, 
2  µg of total RNA was treated with 1.0  unit of DNase 
I in 1.0  μL of 10× reaction buffer (Thermo Scien-
tific) and incubated for 30  min at 37  °C. Total RNA 
was reverse transcribed using a Maxima First Strand 
cDNA synthesis kit (Thermo Scientific) according to 
the manufacturer’s recommendations. Briefly, 2  μg of 
RNA was combined with 0.2 μg of oligo (dT)18 primer 
and RNase-free water for a total volume of 12.0  μL. 
Next, 4.0 μL of 5× reaction buffer, 20 units of Ribolock 
RNase inhibitor, 10  mM dNTP mix, and 200 units of 
RevertAcid M-MuLV reverse transcriptase were added. 
The mixture was incubated at 42  °C for 60  min and 
then heated at 70  °C for 5  min to terminate the reac-
tion. To analyze the transcripts of various cytokines, 
cytokine primers were designed using Lasergene soft-
ware (DNASTAR Inc., Madison, WI, USA) (Table  1). 
Quantitative real-time PCR (qRT-PCR) was performed 
with 2× Power SYBR Green master mix (Roche, IN, 
USA) according to the manufacturer’s instructions, 
using a LightCycler 96 system (Roche). In brief, cDNA 
(100 ng) was added to a reaction mixture of 10 μL 2× 
Power SYBR Green master mix (Roche), 0.5 μL of each 
primer (10  pmol/µL) and RNase-free water for a total 
volume of 20 μL. GAPDH was used as an internal con-
trol to normalize the quantification of target genes. The 
relative quantification of gene-specific expression was 
calculated using the 2−ΔΔCt method after normaliza-
tion with chicken GAPDH [23]. All qRT-PCR reactions 
were performed in triplicate.
Bioinformatics and statistical analyses
Multiple-sequence alignments were analyzed using 
Lasergene software (DNASTAR Inc., Madison, WI, 
USA), and a phylogenetic tree was constructed using 
the neighbor-joining method, with a bootstrap value of 
1000, in the MEGA4 program [24]. Signal peptides and 
N-like glycosylation were predicted using NetNGlyc soft-
ware [25]. Statistical analysis was performed using IBM 
SPSS software (SPSS 21.0 for Windows; SPSS, Chicago, 
IL, USA). The results are expressed as mean ± standard 
error of mean (SEM) at three independent experiments 
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for each group (n  =  3) and were compared between 
groups using the Duncan’s multicomparison method.
Results
Chicken IL‑26
ChIL-26 consists of 82 amino acids and has a predicted 
isoelectric point of 9.6 and a molecular mass of 10.9 kDa 
(Additional file 1). In contrast to HuIL-26, ChIL-26 does 
not contain signal peptides. Moreover, HuIL-26 has two 
glycosylation sites (NFIL and NKGI sites) and ChIL-26 
has three glycosylation sites (NVFS, NACL and NELD 
sites). The ChIL-26 protein has 43.15% and 46.31% 
amino acid similarities to canary and pig IL-26, respec-
tively, whereas the similarities to other mammalian IL-26 
proteins are approximately 23% (Table 2). Analysis of the 
secondary structure showed four highly conserved helix 
structures between ChIL-10 and ChIL-26 (Figure 1A). A 
phylogenetic tree of predicted IL-26 proteins extracted 
from GenBank is shown in Figure 1B. The ChIL-26 pro-
tein comprises a grouping distinct from those of mam-
malian and amphibian species (Figure 1B).
ChIL‑26 receptor complex in T cells
To determine whether ChIL-26 and the ChIL-26 recep-
tor complex, consisting of IL-10R2 and IL-20R1, are 
expressed in T cells and to study this ligand-receptor sys-
tem, we analyzed ChIL-26, IL-10R2 and IL-20R1 mRNA 
expression in the chicken CU91 T cell line and in CD4+ 
Figure 1 Sequence comparison, phylogenetic tree of amino acid and western blot analysis of ChIL-26. A Chicken IL-10 (Accession # NP 
001004414) and ChIL-26 amino acid sequences were aligned and secondary helices of IL-10 and IL-26 were shown in vertical and horizontal lined 
box, respectively. B Phylogenetic tree was constructed by Phylodendron program using amino acid sequences aligned with BioEdit and Mega4 
and (C) Western blot analysis of ChIL-26 recombinant protein. E. coli BL21(DE3) transformed with the pET32a(+)-ChIL-26 plasmid was induced with 
1.0 mM IPTG, purified with a HisPur Cobalt resin and analyzed by Western blotting using anti-His (C-Term)-HRP Antibody.
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and CD8+ T cells. RT-PCR was performed to confirm IL-
10R2 and IL-20R1 mRNA expression and demonstrated 
that the ChIL-10R2 and ChIL-20R1 genes were expressed 
and that ChIL-26 was not expressed in all T cells tested. 
A low expression of IL-10R2 in CD4+ and CD8+ T cell 
compared to CU91 T cell line may be caused by non-
treatment of Con A because CU91 T cell line established 
using interleukin-containing conditioned medium or 
concanavalin A stimulated T cells (Figure 2A). Moreover, 
Con A treatment had an effect on ChIL-26, IL-10R2 and 
IL-20R1 mRNA expression in primary T cells (Figure 2B). 
IL-10R2 mRNA levels increased 3.4-, 4.19- and 5.9-fold 
compared with the control group after Con A treatment 
for 24, 48 (p  <  0.01), and 72  h (p  <  0.001), respectively. 
IL-20R1 mRNA levels also significantly increased (3.5-, 
4.6- and 5.6-fold) compared with the control group, with 
varying levels of significance (Figure  2B). In addition, 
ChIL-26 expression increased considerably (3.8-, 6.9- and 
8.4-fold) compared with the control group, also with var-
ying levels of significance (Figure 2B). Therefore, mRNA 
expression of ChIL-26 and its receptors, IL-10R2 and IL-
20R1, was affected by Con A treatment of splenocytes.
Moreover, the expression of IL-10R2 and IL-20R1 
mRNAs was confirmed in the CU91 T cell line and in 
CD4+ and CD8+ cells by qRT-PCR. The results indicated 
that the expression of IL-10R2 and IL-20R1 genes was 
upregulated in all T cells, particularly those cotreated 
with LPS and ChIL-26, including the CU91 T cell line, 
with 89.0-fold upregulation after 48  h and 88.9-fold 
upregulation after 72 h of treatment (Figure 3). Similar to 
the results obtained for the CU91 T cell line, IL-10R2 and 
IL-20R1 mRNA expression in CD4+ and CD8+ T cells 
was also highly upregulated by LPS/ChIL-26 cotreat-
ment. In CD4+ T cells, IL-10R2 and IL-20R1 were upreg-
ulated 17.5- and 13.8-fold after 48 h treatment, and these 
receptors were increased 6.1-fold after 24 h and 5.5-fold 
after 72 h treatment with LPS/ChIL-26 in CD8+ T cells 
(Figure 3). This observation suggested that IL-10R2 and 
IL-20R1 are expressed on T cells and may be two chain 
for the chicken IL-26 receptor complex.
Table 1 Primer sequences for real-time PCR analyses of 
cytokine transcript expression
Primer F/R Nucleotide sequencing (5′‑3′) Accession no
GAPDH Forward TGC TGC CCA GAA CAT CAT CC NM_204305
Reverse ACG GCA GGT CAG GTC AAC AA
CCL3 Forward CAT TGC CTC CGC CTA CAT EU999777
Reverse ACT CCT CGG GGT TTA CAC ATA
CCL4 Forward CCC CTT GTC ATC GGT CAC NM_204720
Reverse AGA GGC AGG AGC AGA GCA
CCL5 Forward CAG CAA ATG CCC ACA GG NM_001045832
Reverse TGC AGC TCC AGG AAG TTG AT
CCL20 Forward AGG CAG CGA AGG AGC AC NM_204438
Reverse GCA GAG AAG CCA AAA TCA AAC
CXCL13 Forward GCC TGT GCC TGG TGC TC XM_420474.4
Reverse TGC CCC CTT CCC CTA AC
IFN-γ Forward AGC TGA CGA CGG TGG ACC TAT TAT T HQ739082
Reverse GGC TTT GCG CTG GAT TC
IL-4 Forward AGC ACT GCC ACA AGA ACC TG NM_001007079
Reverse CCT GCT GCC GTG GGA CAT
IL-6 Forward CAA GGT GAC GGA GGA GGA C JQ897539
Reverse TGG CGA GGA GGG ATT TCT
IL-8 
(CXCLi2)
Forward GGC TTG CTA GGG GAA ATG A NM_205498
Reverse AGC TGA CTC TGA CTA GGA AAC TGC
IL-10 Forward CTG TCA CCG CTT CTT CAC CT AJ621254
Reverse ACT CCC CCA TGG CTT TGT A
IL-16 Forward TGC CTC ACA AGA ATC AAC AAC T AB104417.2
Reverse ATA GAG CCC TTC CCA CCT TC
IL-17A Forward TGT CTC CGA TCC CTT GTT CT AM773756
Reverse GTC CTG GCC GTA TCA CCT T
IL-17D Forward ACC CCA CAA GAT ACC CTA AAT AC EF570583
Reverse GTG CTG CGG AAG TGA AAA T
IL-17F Forward CTC CGA TCC CTT ATT CTC CTC NM_204460
Reverse GTC CTG GCC GTA TCA CCT T
IL-18 Forward ATT TTC CCA TGC TCT TTC TCA HM854281
Reverse GGA ATG CGA TGC CTT TTG
IL-26 Forward AAT GCC TGT CTT CCG TGT G XM_004937561
Reverse TCA TTG ATG GCC TTG TAG ACC
TNFSF15 Forward CCT GAG TAT TCC AGC AAC GCA NM_001024578
Reverse ATC CAC CAG CTT GAT GTC ATC AAC
IL-10R2 Forward GAG CAG ACC ACC CAT AAC G NM_204857
Reverse ATA CCA AAA GGC AAA GAA ACA A
IL-20R1 Forward GTG GAT GAA TTG CTG GGT AAG XM_419723
Reverse TCT GTG ATG CCG TGT GCT AT
Table 2 Chicken IL-26 amino acid similarity and identity 
with other species
The amino acid similarity and identity were analyzed using BLASTP with a 
BLOSUM62 scoring matrix.
Chicken Accession no
Similarity (%) Identity (%)
Human 27.36 22.63 NP_060872
Fish 22.1 20 NP_001018635
Baboon 27.89 22.63 XP_003906792
Canary 46.84 43.15 XP_009093343
Chimpanzee 27.36 22.63 XP_003808754
Camelus 23.68 21.57 AIL25449
Polar bear 28.42 23.15 XP_008682482
Cat 27.89 22.63 XP_006933945
Cattle 28.42 23.15 XP_005909110
Pig 48.94 46.31 ABJ96481
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Costimulation with LPS/ChIL‑26 leads to proinflammatory 
cytokine and chemokine expression in T cells
Previous reports demonstrated that HuIL-26 induces 
Th1 and Th17 as well as Th2 cytokines [14, 26]; there-
fore, we examined the transcriptional targets of this 
cytokine. The role of ChIL-26 in the transcriptional 
regulation of Th17 cytokines involved the induction of 
IL-17A, IL-17D and IL-17F cytokines. LPS and ChIL-26 
treatment significantly enhanced the expression of IL-
17A and IL-17D in all T cells at 72 h. In addition, IL-17F 
expression was also increased in the CU91 T cell line 
and in CD4+ and CD8+ cells at all time points, when 
cells were treated with LPS/ChIL-26 (Figure  4; Addi-
tional files 2 and 3). The IL-26-regulated expression of 
IL-17A, IL-17D and IL-17F by T cells and particularly in 
CU91 T cell line.
The levels of the IL-4, IL-6, and IL-10 cytokines, 
which correspond to Th2 cytokines in birds, signifi-
cantly increased following stimulation with LPS and 
ChIL-26 compared to the control. IL-4 mRNA was 
highly increased at 72  h, and its levels maximized at 
131-, 16.4- and 13.8-fold in the CU91 T cell line and in 
CD4+ and CD8+ T cells, respectively compared to the 
control (p  <  0.001) (Figure  4; Additional files 2 and 3). 
The expression of IL-6 and IL-10 mRNAs also increased 
significantly at 24 h post-LPS/ChIL-26 stimulation com-
pared to the control in all T cells (p  <  0.001) (Figure  4; 
Additional files 2 and 3).
IL-18 mRNA was not increased in the CU91 T cell 
line stimulated with LPS or ChIL-26, or both, however it 
increased 4.4-fold with LPS and ChIL-26 or with ChIL-
26 only in CD4+ and CD8+ T cells (p < 0.05) (Figure 4; 
Additional files 2 and 3). The expression of IFN-γ, a 
Th1 cytokine, also increased, and reached its maximum 
expression level after 72 h of costimulation with LPS and 
ChIL-26 in all T cells (p < 0.01) (Figure 4; Additional files 
2 and 3).
IL-16 mRNA was also highly expressed 24  h after 
costimulation in the CU91 T cell line and in CD4+ T cells 
and at 72  h in CD8+ T cells (p  <  0.01) (Figure  4; Addi-
tional files 2 and 3). The LPS and ChIL-26 combination 
also had a positive effect on chemokine expression in T 
cells. When LPS and ChIL-26 were used in combination, 
the expression of CCL3, CCL4, CCL20, and CXCL13 
mRNAs increased significantly in the CU91 T cell line at 
24 h, in CD4+ cells at 24 h (CCL4 and CCL20) and 48 h 
Figure 2 Receptors and GAPDH are expressed but not IL-26 are expressed in T cell. A IL-10 receptor 2 and IL-20 receptor 1 are expressed, 
but IL-26 is not expressed in T cell (T cell line, CD4+ T cell and CD8+ T cell). B IL-10R2, IL-20R1 and IL-26 expression in primary T cell induced by Con A 
(5 µg/mL), respectively. The expression of IL-10R2, IL-20R1 and IL-26 mRNA as analyzed by qRT-PCR analysis of mRNA derived from T cell as indicated. 
Data are presented as the mean ± SEM (n = 3) of three independent experiments: *p < 0.05, **p < 0.01, and ***p < 0.001.
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(CXCL13), and CD8+ cells at 24  h (CCL3 and CCL20) 
and 72  h (CCL4 and CXCL13) compared with controls 
(p < 0.001) (Figure 4; Additional files 2 and 3). The expres-
sion of CCL5 and IL-8 (CXCLi2) mRNAs increased sig-
nificantly compared with controls at 48  h (p  <  0.001) 
(Additional files 2). In CD4+ and CD8+ T cells, the high-
est expression levels of all chemokines measured over all 
time points were seen with LPS and ChIL-26 treatments. 
Collectively, these results demonstrated that ChIL-26 
upregulates the expression of proinflammatory cytokines 
and chemokines mRNA in the CU91 T cell line and in 
CD4+ and CD8+ T cells.
Discussion
This is the first report demonstrating a role for ChIL-
26 in chickens. ChIL-26 is a novel member of the IL-
10-like cytokine family and shares the IL-10R2 subunit 
with IL-10 [27] and the IL-20R1 subunit with IL-20 
[28]. The IL-26 gene and its corresponding protein 
also share some sequence homology with HuIL-10 
and ChIL-10. IL-10 has anti-inflammatory properties, 
however we demonstrated here that IL-26 has proin-
flammatory functions in T cells and induces cytokine 
upregulation upon costimulation with LPS. Other 
research groups first identified the receptors for HuIL-
26 [8, 11]. HuIL-26 signals through a heterodimeric 
receptor complex composed of IL-20R1 and IL-10R2 
chains. IL-20R1 functions as the specific ligand binding 
chain for IL-26, and IL-10R2 functions as an essential 
second chain to complete assembly of the active recep-
tor complex. Similar to humans, signaling via chicken 
IL-10R2 and IL20R1 is also activated by LPS and ChIL-
26 costimulation (Figure  3). Neutralizing antibodies 
against either the IL-20R1 or IL-10R2 chain can block 
induction of HuIL-26 signaling [8, 11]. In contrast to 
the anti-inflammatory properties of IL-10, we dem-
onstrated that ChIL-26 modulates the proinflamma-
tory functions of T cells. Similar to HuIL-26, ChIL-26 
upregulates the gene expression of proinflammatory 
cytokines in T cells.
Depending on the T cell source, cytokines have been 
differentiated into Th1, Th2 and Th17 cytokines. Pre-
vious studies demonstrated an induction of HuIL-26 
production particularly in Th1 cells [14]. Crohn’s dis-
ease is considered to represent Th1- and Th17-medi-
ated intestinal inflammation, while ulcerative colitis 
Figure 3 Interleukin 20 receptor 1 (IL-20R1) and interleukin 10 receptor 2 (IL-10R2) expressed in T cell. IL-20R1 and IL-10R2 mRNA 
expressed in CU91 T cell line, CD4+ T cell and CD8+ T cell as demonstrated by quantitative RT-PCR. Data are presented as the mean ± SEM (n = 3) of 
three independent experiments: *p < 0.05, **p < 0.01, and ***p < 0.001.
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Figure 4 ChIL-26/LPS induces cytokine secretion by CD8+ T cells. The CD8+ T cell line was cultured in the presence or absence of 200 ng/mL 
ChIL-26, with or without 5 µg/mL LPS, and cytokine expression was analyzed by qRT-PCR. The results are indicated as fold increases of mRNA expres-
sion compared to that in unstimulated control cells. Data are presented as the mean ± SEM (n = 3) of three independent experiments: *p < 0.05, 
**p < 0.01, and ***p < 0.001.
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has features, at least to some degree, of Th2-mediated 
colitis [29–31]. Our studies demonstrated that ChIL-
26 strongly induces Th1 cytokines (IL-16 and IFN-γ; 
but with an absence of IL-18 in the CU91 T cell line), 
Th2 cytokines (IL-4, -6 and -10), Th17 cytokines (IL-
17A, IL-17D and IL-17F), and chemokines (mainly 
CCL3, CCL4, CCL5, CCL20, CXCLi2 and CXCL13) in 
T cells (Figure 4; Additional files 2 and 3). Overall, the 
cytokine and chemokine genes were expressed more 
highly in the CU91 T cell line than in CD4+ and CD8+ 
T cells upon costimulation with LPS and ChIL-26. 
Researcher groups previously reported that resting T 
cells expressed lager diversity of genes and the patterns 
of gene expression showed markedly downregulation 
than transformed T cells cause by the different pathway 
involving antigen-presenting cell [32–34]. Therefore, 
the differences in gene expression for the CU91 T cell 
line and CD4+ and CD8+ T cells may result from dis-
parities in the efficiency of antigen presentation via the 
MHC class I and II pathways, in the context of LPS and 
ChIL-26 cotreatment [35–37].
Avian IL-26 is another member of the IL-10 family, 
and chicken T cells express a functional IL-26 recep-
tor complex (IL10R2 and IL-20R1). LPS binds to Toll-
like receptor 4 (TLR4) on the cell surface and forms 
the LPS-TLR4 complex, which triggers both MyD88-
dependent and MyD88-independent TRIF-dependent 
pathways. Toll-like receptor (TLR) family including 
TLR-4 expressed in chicken immune T cell subsets 
(CD4+ and CD8+ T cell) and cell lines (B and T cell 
lines) [38]. Signaling through the MyD88-dependent 
pathway is responsible for early-phase NF-κB and 
MAPK activation, which facilitates the induction of 
proinflammatory cytokines, chemokines, adhesion 
molecules, and MHC or costimulatory molecules [39]. 
As expected, the cytokines in T cells were significantly 
more highly expressed in cells receiving LPS/ChIL-26 
costimulation than in cells treated with either LPS or 
ChIL-26 alone.
Here, we demonstrated the successful cloning and 
expression of ChIL-26 and its molecular functions in 
immune responses in the CU91 chicken T cell line and 
CD4+ and CD8+ T cells. In this study, the use of ChIL-
26-deficient T cells revealed that ChIL-26 expression is 
necessary for optimal LPS induction of several cytokines. 
Therefore, we suggest that ChIL-26 as well as patho-
gens may influence the expression of Th1, Th2 and Th17 
cytokines. Further investigation into the regulation of 
ChIL-26 gene expression with signaling pathway will 
undoubtedly reveal new insights into the regulation of T 
cell proinflammatory gene programs.
Abbreviations
MHC: major histocompatibility complex; TCR: T cell receptor; CTLs: cytotoxic T 
lymphocytes; NKs: natural killer cells; IL: interleukin; TNF: tumor necrosis factor; 
RT: reverse transcription; IPTG: isopropyl β-d-1-thiogalactopyranoside; MAPK: 
mitogen-activated protein kinase; TLR: toll-like receptor.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
Conceived and designed the experiments: ADT, YHH. Performed the experi-
ments: ADT, BP and JB. Analysed the data: ADT, BP, JB and YHH. Contributed 
reagents/materials/analysis tools: YHH. Wrote the paper: ADT, YHH. Interpreted 
the data: ADT, YHH. All authors read and approved the final manuscript.
Acknowledgements
This research was supported by the Golden Seed Project (PJ009925022016), 
the Ministry of Agriculture, Food and Rural Affairs (MAFRA), the Ministry of 
Oceans and Fisheries (MOF), the Rural Development Administration (RDA) 
and the Korea Forest Service (KFS) and by the Chung-Ang University Excellent 
Student Scholarship in 2014. We kindly thank Dr Hyun S. Lillehoj for providing 
the chicken samples.
Received: 4 August 2015   Accepted: 3 May 2016
References
 1. Knappe A, Hor S, Wittmann S, Fickenscher H (2000) Induction of a novel 
cellular homolog of interleukin-10, AK155, by transformation of T lym-
phocytes with herpesvirus saimiri. J Virol 74:3881–3887
 2. Igawa D, Sakai M, Savan R (2006) An unexpected discovery of two 
interferon gamma-like genes along with interleukin (IL)-22 and -26 from 
teleost: IL-22 and -26 genes have been described for the first time outside 
mammals. Mol Immunol 43:999–1009
 3. Gallagher G, Dickensheets H, Eskdale J, Izotova LS, Mirochnitchenko OV, 
Peat JD, Vazquez N, Pestka S, Donnelly RP, Kotenko SV (2000) Cloning, 
expression and initial characterization of interleukin-19 (IL-19), a novel 
homologue of human interleukin-10 (IL-10). Genes Immun 1:442–450
 4. Conti P, Kempuraj D, Frydas S, Kandere K, Boucher W, Letourneau R, 
Madhappan B, Sagimoto K, Christodoulou S, Theoharides TC (2003) IL-10 
subfamily members: IL-19, IL-20, IL-22, IL-24 and IL-26. Immunol Lett 
88:171–174
Additional files
Additional file 1. Nucleotide and deduced amino acid sequences 
of ChIL-26. The primers used to amplify the full-length ChIL-26 sequence 
are underlined.
Additional file 2. ChIL-26/LPS induces cytokine secretion by the 
CU91 T cell line. The CU91 chicken T cell line was cultured in the pres-
ence or absence of 200 ng/mL ChIL-26, with or without 5 µg/mL LPS, and 
cytokine expression was analyzed by qRT-PCR. The results are indicated 
as fold increases of mRNA expression compared to that in unstimulated 
control cells. Data are presented as the mean ± SEM (n = 3) of three inde-
pendent experiments: * p < 0.05, ** p < 0.01, and *** p < 0.001.
Additional file 3. The CD4+ T cell line was cultured in the pres-
ence or absence of 200 ng/mL ChIL-26, with or without 5 µg/mL 
LPS, and cytokine expression was analyzed by qRT-PCR. The results 
are indicated as fold increases of mRNA expression compared to that in 
unstimulated control cells. Data are presented as the mean ± SEM (n = 3)  
of three independent experiments: * p < 0.05, ** p < 0.01, and *** p < 0.001.
Page 10 of 10Truong et al. Vet Res  (2016) 47:65 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 5. Kotenko SV (2002) The family of IL-10-related cytokines and their recep-
tors: related, but to what extent? Cytokine Growth Factor Rev 13:223–240
 6. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson 
JD, Basham B, Smith K, Chen T, Morel F, Lecron JC, Kastelein RA, Cua DJ, 
McClanahan TK, Bowman EP, de Waal Malefyt R (2007) Development, 
cytokine profile and function of human interleukin 17-producing helper 
T cells. Nat Immunol 8:950–957
 7. Donnelly RP, Sheikh F, Dickensheets H, Savan R, Young HA, Walter MR 
(2010) Interleukin-26: an IL-10-related cytokine produced by Th17 cells. 
Cytokine Growth Factor Rev 21:393–401
 8. Hor S, Pirzer H, Dumoutier L, Bauer F, Wittmann S, Sticht H, Renauld JC, de 
Waal Malefyt R, Fickenscher H (2004) The T-cell lymphokine interleukin-26 
targets epithelial cells through the interleukin-20 receptor 1 and interleu-
kin-10 receptor 2 chains. J Biol Chem 279:33343–33351
 9. Kaiser P, Poh TY, Rothwell L, Avery S, Balu S, Pathania US, Hughes S, Good-
child M, Morrell S, Watson M, Bumstead N, Kaufman J, Young JR (2005) 
A genomic analysis of chicken cytokines and chemokines. J Interferon 
Cytokine Res 25:467–484
 10. Kaiser P (2007) The avian immune genome–a glass half-full or half-
empty? Cytogenet Genome Res 117:221–230
 11. Sheikh F, Baurin VV, Lewis-Antes A, Shah NK, Smirnov SV, Anantha S, 
Dickensheets H, Dumoutier L, Renauld JC, Zdanov A, Donnelly RP, 
Kotenko SV (2004) Cutting edge: IL-26 signals through a novel receptor 
complex composed of IL-20 receptor 1 and IL-10 receptor 2. J Immunol 
172:2006–2010
 12. Dambacher J, Beigel F, Zitzmann K, De Toni EN, Goke B, Diepolder HM, 
Auernhammer CJ, Brand S (2009) The role of the novel Th17 cytokine 
IL-26 in intestinal inflammation. Gut 58:1207–1217
 13. Nagalakshmi ML, Murphy E, McClanahan T, de Waal Malefyt R (2004) 
Expression patterns of IL-10 ligand and receptor gene families provide 
leads for biological characterization. Int Immunopharmacol 4:577–592
 14. Corvaisier M, Delneste Y, Jeanvoine H, Preisser L, Blanchard S, Garo E, 
Hoppe E, Barre B, Audran M, Bouvard B, Saint-Andre JP, Jeannin P (2012) 
IL-26 is overexpressed in rheumatoid arthritis and induces proinflam-
matory cytokine production and Th17 cell generation. PLoS Biol 
10:e1001395
 15. Sedwick C (2012) IL-26 kick-starts rheumatoid arthritis. PLoS Biol 
10:e1001398
 16. Yang HQ, Liu XG, Yang X, Chen T, Yu SG (2013) Effect of different types 
of moxibustion intervention on expression of inflammatory cytokines 
IL-1 and TNF-alpha in rabbits with rheumatoid arthritis. Zhen Ci Yan Jiu 
38:134–139 (in Chinese)
 17. Braum O, Klages M, Fickenscher H (2013) The cationic cytokine IL-26 dif-
ferentially modulates virus infection in culture. PLoS One 8:e70281
 18. Hong YH, Song W, Lee SH, Lillehoj HS (2012) Differential gene expres-
sion profiles of beta-defensins in the crop, intestine, and spleen using a 
necrotic enteritis model in 2 commercial broiler chicken lines. Poultry Sci 
91:1081–1088
 19. Reichelt P, Schwarz C, Donzeau M (2006) Single step protocol to purify 
recombinant proteins with low endotoxin contents. Protein Expr Purif 
46:483–488
 20. Hong YH, Lillehoj HS, Lee SH, Dalloul RA, Lillehoj EP (2006) Analysis of 
chicken cytokine and chemokine gene expression following Eimeria 
acervulina and Eimeria tenella infections. Vet Immunol Immunopathol 
114:209–223
 21. Annamalai T, Selvaraj RK (2010) Chicken chemokine receptors in T cells 
isolated from lymphoid organs and in splenocytes cultured with conca-
navalin A. Poult Sci 89:2419–2425
 22. Schat KA, Pratt WD, Morgan R, Weinstock D, Calnek BW (1992) Stable 
transfection of reticuloendotheliosis virus-transformed lymphoblastoid 
cell lines. Avian Dis 36:432–439
 23. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data 
using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. 
Methods 25:402–408
 24. The MEGA4 homepage http://www.megasoftware.net/mega4/. 
Accessed 27 Dec 2014
 25. The NetNGlyc homepage http://www.cbs.dtu.dk/services/NetNGlyc/. 
Accessed 30 Dec 2014
 26. Alanara T, Karstila K, Moilanen T, Silvennoinen O, Isomaki P (2010) Expres-
sion of IL-10 family cytokines in rheumatoid arthritis: elevated levels of 
IL-19 in the joints. Scand J Rheumatol 39:118–126
 27. Yao Q, Fischer KP, Arnesen K, Lorne Tyrrell D, Gutfreund KS (2013) The 
Pekin duck IL-10R2 common chain: cDNA cloning, genomic structure, 
molecular characterization and mRNA expression analysis. Int J Immuno-
genet 40:386–395
 28. Commins S, Steinke JW, Borish L (2008) The extended IL-10 superfamily: 
IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. J Allergy Clin Immunol 
121:1108–1111
 29. Bouma G, Strober W (2003) The immunological and genetic basis of 
inflammatory bowel disease. Nat Rev Immunol 3:521–533
 30. Neurath MF (2007) IL-23: a master regulator in Crohn disease. Nat Med 
13:26–28
 31. Dige A, Stoy S, Rasmussen TK, Kelsen J, Hvas CL, Sandahl TD, Dahlerup JF, 
Deleuran B, Agnholt J (2013) Increased levels of circulating Th17 cells in 
quiescent versus active Crohn’s disease. J Crohns Colitis 7:248–255
 32. Teague TK, Hildeman D, Kedl RM, Mitchell T, Rees W, Schaefer BC, Bender 
J, Kappler J, Marrack P (1999) Activation changes the spectrum but not 
the diversity of genes expressed by T cells. Proc Natl Acad Sci U S A 
96:12691–12696
 33. Chtanova T, Newton R, Liu SM, Weininger L, Young TR, Silva DG, Bertoni F, 
Rinaldi A, Chappaz S, Sallusto F, Rolph MS, Mackay CR (2005) Identifica-
tion of T cell-restricted genes, and signatures for different T cell responses, 
using a comprehensive collection of microarray datasets. J Immunol 
175:7837–7847
 34. Weng NP, Araki Y, Subedi K (2012) The molecular basis of the memory T 
cell response: differential gene expression and its epigenetic regulation. 
Nat Rev Immunol 12:306–315
 35. Qi Y, Operario DJ, Georas SN, Mosmann TR (2012) The acute environment, 
rather than T cell subset pre-commitment, regulates expression of the 
human T cell cytokine amphiregulin. PLoS One 7:e39072
 36. Ribas A, Butterfield LH, Economou JS (2000) Genetic immunotherapy for 
cancer. Oncologist 5:87–98
 37. Watts C (1997) Capture and processing of exogenous antigens for pres-
entation on MHC molecules. Annu Rev Immunol 15:821–850
 38. Iqbal M, Philbin VJ, Smith AL (2005) Expression patterns of chicken Toll-
like receptor mRNA in tissues, immune cell subsets and cell lines. Vet 
Immunol Immunopathol 104:117–127
 39. Lu YC, Yeh WC, Ohashi PS (2008) LPS/TLR4 signal transduction pathway. 
Cytokine 42:145–151
